Best Orthopedics Companies in New Jersey, United States

Onkos Surgical is focused on developing implants and instruments for musculoskeletal tumor patients. The Guardian Limb Salvage System is designed to provide options for patients when a surgical intervention is required due to cancer or metastatic diseases. The system is indicated for procedures when a radical resection and replacement of the proximal tibia and/or proximal, distal and/or total femur is required. They use 3D technology to develop modular systems patient specific products. Its solutions include the GUARDIAN Limb Salvage System which includes hinges for the femur and tibia for indications during surgical intervention. It has partnered with Vivex Biomedical to provide a portfolio of tissue products to support the needs of musculoskeletal oncologists. The company's uDesign Patient Solutions is a combination of advanced 3D printing technologies, limb restoration technologies, and biologic solutions.

Funding rounds

• Jan 2025Venture Debt$35M
• May 2023Series C$33.5M
• Apr 2020Series B$10.1M
• Jul 2019Series B$22.6M

Founders & team

Patrick TreacyCo-Founder & CEOAntony KoblishCo-Founder

Investors

1315 Capital, Canaan, 3D Systems, Horizon, Rocky Point Ventures, SV Health Investors

Tech stack

Animate.CssCloudflareCloudflare Bot ManagementFancyboxFont AwesomeGodaddy

Innovating women's pelvic healthcare with biomechanical mapping and digital twin technologies. The company is a medical device developer and manufacturer focused on women's healthcare, pioneering novel devices for diagnosing and evaluating vaginal and pelvic floor conditions. They create unique tactile and ultrasound imaging devices, including the Vaginal Tactile Imager and Vaginal Tactile Ultrasound Imager, to aid in the diagnosis of pelvic conditions. Committed to advancing diagnostic and treatment capabilities, they actively pursue clinical research partnerships. Their work aims to quantify the sense of touch, providing valuable information for healthcare professionals. They are focused on biomechanical mapping, digital twin technologies, and women's health.

Funding rounds

• Aug 2025Grant (prize money)$299.9K
• Jan 2025Grant (prize money)$299.9K
• May 2023Grant (prize money)$299.9K
• Sep 2019Grant (prize money)$224.9K

Founders & team

Vladimir EgorovChairman and Chief Executive Officer

Investors

HHS

Tech stack

Cart FunctionalitySquarespace CommerceSquarespaceStimulusPriority HintsGoogle Font Api

Innovating orthobiologics and wound care solutions for enhanced healing. A premier orthobiologics and life science company dedicated to innovating and advancing cutting-edge solutions that enhance healing across diverse clinical applications. The mission centers on leveraging Autologous and Live Cellular therapies to address a wide spectrum of musculoskeletal and regenerative medicine challenges through a comprehensive product portfolio. They prioritize patients by providing innovative wound care and biologic solutions that enhance healing and improve quality of life. A pioneering leader in orthobiologic and wound care research and development, they deliver top-tier, innovative biologic solutions that enhance the healing process and improve patients' quality of life. Driven by patient-centered care, innovation and excellence, and integrity and compassion, they provide a comprehensive array of products tailored to meet the varied needs of the orthobiologic and wound care industry. They are continuously developing and launching new products and solutions that set benchmarks for quality, effectiveness, and patient outcomes. Their commitment to research and innovation keeps it at the f

Funding rounds

• Feb 2025Series A$19.6M
• Jun 2019Seed—

Founders & team

Salvatore LeoCEO

Investors

Granite Creek Capital Partners

Developing personalized neurorehabilitation exergames. The company creates fun, engaging exergames to improve hand and arm function in children and adults. These products utilize technology and research in brain plasticity, offering gamified rehabilitation with remote or in-person clinician supervision and progress tracking. The system is designed for use in various settings, including hospitals, outpatient centers, schools, and homes, providing a cost-effective solution to improve patient outcomes. The exergames aim to enhance rehabilitation and improve quality of life for individuals with disabilities.

Funding rounds

• May 2025Grant (prize money)$575K
• Sep 2024Grant (prize money)$287.5K
• Jun 2022Grant (prize money)$100K
• May 2021Grant (prize money)$276K

Founders & team

Amanda GrossCo-Founder & CTO

Investors

HHS

Developer of therapies for preventing metastasis and recurrence of cancers. It offers a lead candidate VUJ-100 that has anti metastatic activity based on properitory platform for multiple metastatic osteosarcoma and other cancer models.

Developer of a surgical robot for long-bone fracture alignment. The system includes a surgical robot, imaging software, and a haptic controller. It enables surgeons to apply traction forces and precisely align fractured bones. The system utilizes imaging technology to automatically align bone fragments. It reduces radiation exposure during the alignment procedure.

Funding rounds

• Jul 2025Seed$110K
• Jul 2022Seed$150K

Founders & team

Mohammad Abedin-NasabFounder & CEO

Developer of regenerative products for musculoskeletal injury and disease. The company has Citrelock tendon fixation devices, Citrefix knotless suture anchor devices, and Citrespline to protect tendons and ligaments. These devices are based on Citregen biomaterial technology which is a bioresorbable synthetic polymer helps in tissue regeneration.

Developer of nucleic acid therapeutics for cancer and rare muscular disorders. The company is developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology to deliver nucleic acid payloads, including mRNA, DNA, siRNA, and ASOs. The company's initial focus is to treat cancers, Duchenne muscular dystrophy (DMD), and other rare muscle diseases.

Funding rounds

• Dec 2022Series B$15M
• Dec 2021Series A$1M
• May 2021Series A$10M

Founders & team

Peter GlazerCo-FounderChris DukeChief Executive Officer

Investors

CureDuchenne, Orbimed

Viscoelastic spinal disc replacement technology restoring normal spine motion and shock absorption. The company specializes in developing and manufacturing next-generation artificial discs using proprietary viscoelastic polymer technology. Their focus is on providing innovative solutions for patients with degenerative spine conditions, offering an alternative to fusion and first-generation artificial discs. The company's primary goal is to restore normal spine movements by replacing diseased spine discs, emulating a healthy disc to reestablish normalcy. They are also developing smart sensor technologies for spine and orthopedic medical devices, aiming to revolutionize outcome monitoring and optimization in musculoskeletal care. Their products are designed to facilitate pain relief and restoration of normal spinal function for patients with degenerative disc disease.

Developer of orthopedic-assited surgery devices. The company has developed products such as MOBIO Total Knee System, KOSMO Stem, JUVENO Stem, and PRIMO Acetabular System.

Developer of minimally invasive products for musculoskeletal procedures. The company develops, manufactures, and markets orthopedic implants, including those for the spine, trauma, and artificial joints.

Surgical therapeutic devices using a first-in-class materials science platform. The company focuses on developing and manufacturing innovative therapeutic devices for surgical procedures. Their solutions aim to consolidate features and benefits that surgeons desire into easy-to-use products. They offer water-soluble, hemostatic bone putty, including options in syringe-like applicators and containing HA/β-TCP. A key product is a cohesive, settable, and resorbable hemostatic bone putty that adheres to bleeding bone surfaces and is putty-like immediately upon opening. Their products are designed for ease-of-use in various surgical fields, including ortho, trauma, spine, sports medicine, cranial, maxillofacial, and cardiothoracic procedures. The company operates in the B2B space, providing specialized medical devices to healthcare professionals.